Tim HayesQuick HitsFDA Clears Zepbound for Weight LossThe Agency gave the green light to another diabetes drug turned weight loss aid offering new hope in the battle against obesity.November 15, 2023Quick HitsCleveland Clinic's Prescription Drone DeliveryMedication delivery with a cutting-edge drone service, ensures quicker and more convenient access to prescriptions for patients.November 14, 2023Quick HitsJnJ Surgery Robot Moves Closer to FDA Clinical TrialsThe robot could revolutionize surgical procedures with its adaptability and precision.November 13, 2023Quick HitsOxygen-Generating Patch Accelerates Wound HealingThe adhesive patch not only seals wounds–it also generates oxygen to supercharge the healing process.November 10, 2023Quick HitsBlood Test Offers Early Lung Cancer DetectionThe NeXT Personal ctDNA assay offers the potential for early detection, improving the prognosis and enabling more precise monitoring.November 9, 2023Quick HitsWireless Pacemaker Converts Heart's EnergyThe device converts mechanical energy into electrical power, potentially extending battery life and reducing the need for multiple implants.November 8, 2023Quick HitsHigh Demand Strains Weight-Loss Drug SupplyNovo Nordisk and Eli Lilly are witnessing soaring demand for their diabetes and weight-loss drugs.November 7, 2023Quick HitsInnovative Magnetoelectric Material for Nerve StimulationRice University's injectable magnetoelectric material offers non-invasive neural stimulation for potential use in neuroprosthetics.November 6, 2023Quick HitsSupply and Demand: The ADHD Medication QuandaryADHD medication shortages due to high demand and manufacturing delays are leading people to seek alternatives or reduced doses.November 3, 2023Quick HitsFDA Warns Against 26 Eye Drop Products Over Infection RiskThe specific bacteria strain found in the recent contamination was not specified in the FDA's notice.November 2, 2023Previous PagePage 4 of 168Next PageTop StoriesTemp Control/Cold ChainThrough the Line Podcast: Digital Solutions Improve Serialization and Cold Chain ManagementWith biologics comprising over 40% of drugs in development, the need for precise temperature control is paramount. These drugs typically require refrigeration at temperatures between two to eight degrees Celsius (or even lower) and falling outside that range could affect efficacy and patient safety.PMMI NewsMeeting Sustainability Goals Requires CollaborationTemp Control/Cold ChainTeva Pharmaceuticals Proves Sea Freight Viability for Temperature-Sensitive MedicinesNutraceuticals/DietaryReviving Manufacturing, Redefining Packaging: How Graasi Is Building a Sustainable Future for NutraceuticalsSponsor ContentMore Than a Label: How ECLs Deliver Critical Value in Patient Adherence and Safety
